Related Subjects:
|Acute Stroke Assessment (ROSIER&NIHSS)
|Atrial Fibrillation
|Atrial Myxoma
|Causes of Stroke
|Ischaemic Stroke
|Cancer and Stroke
|Cardioembolic stroke
|CT Basics for Stroke
|Endocarditis and Stroke
|Haemorrhagic Stroke
|Stroke Thrombolysis
|Hyperacute Stroke Care
π§ Introduction
Cardioembolic stroke = cerebral ischaemia from emboli arising in the π heart (atria, ventricles, valves) that travel to cerebral arteries.
π Also includes paradoxical emboli via PFO/ASD.
π They account for 15β30% of all ischaemic strokes, with mortality up to 30%.
β‘ In those >80y, >20% of strokes are AF-related β major prevention opportunity with anticoagulation.
π₯ Causes & Sources
- High Risk Sources:
- π« Atrial fibrillation (AF): Valvular & non-valvular; risk stratified by CHA2DS2-VASc.
- β€οΈ Recent MI: esp. LV aneurysm/hypokinesia.
- βοΈ Mechanical valves: very thrombogenic.
- π« Dilated cardiomyopathy: chamber stasis β thrombus.
- π« Rheumatic mitral stenosis: atrial enlargement + stasis.
- Other Sources:
- π¦ Infective endocarditis: septic vegetations embolise.
- π Atrial myxoma: fragments embolise.
- π PFO: paradoxical embolus from venous system.
- π LAA thrombus: classic in AF.
- πͺ¨ Mitral prolapse/calcification: thrombogenic.
- 𧬠Marantic endocarditis: malignancy, SLE.
π Classification
- π Cardiac wall/chamber: cardiomyopathies, LV aneurysm, atrial septal aneurysm, myxoma, fibroelastomas, thrombi, septal defects (PFO/ASD).
- π« Valvular disease: RHD, prosthetic valves, infective or LibmanβSacks endocarditis, MVP, annular calcification.
- β‘ Arrhythmias: AF, flutter, sick sinus syndrome.
π©Ί Clinical Features
- β‘ Sudden onset, deficits maximal at onset.
- π Multiple territories can be affected.
- βοΈ Fluctuating symptoms if embolus fragments.
- π Large vessel occlusion: MCA, ICA, PCA.
- π©Έ High risk of haemorrhagic transformation.
- π§ββοΈ May present with β consciousness, seizures at onset.
π Look for cardiac signs: irregular pulse (AF), murmurs, heart failure, IE stigmata.
π Causes & Frequency
- AF (non-valvular): ~50% β stroke risk β3β5x.
- Recent MI: ~10% β esp. anterior MI, early weeks.
- LV thrombus: ~10% β echo for detection.
- Rheumatic MS: ~10% β very high embolic risk.
- Mechanical valves: ~5% β lifelong warfarin.
- Other (tumours, IE, PFO): ~15%.
π Structural Heart Disease
- π Cardiomyopathy (dilated, hypertrophic, restrictive).
- π¦ Infective endocarditis.
- π Atrial myxoma (constitutional + embolic signs).
- π©Έ LV aneurysm post-MI.
- πͺ¨ Mitral valve prolapse/calcification.
- π PFO in cryptogenic stroke (younger pts).
π§ͺ Investigations
- π©Έ Bloods: FBC, coagulation, ESR, cultures (if IE suspected).
- π ECG: AF, MI changes.
- π‘ Holter: detect paroxysmal AF.
- πΌ CT/MRI brain: multiple embolic infarcts, DWI sensitive.
- π§² CTA/MRA: vessel occlusions.
- π« Echo:
- TTE: chamber size, LV function.
- TEE: LAA thrombus, vegetations, PFO (with bubble study).
- π§ TCD: detect microemboli, shunts.
βοΈ Management
- π¨ Acute stroke protocols: reperfusion therapy (IVT/thrombectomy) as per guidelines.
- π Anticoagulation:
- DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) for non-valvular AF.
- Warfarin for mechanical valves & rheumatic MS (DOACs not licensed).
- Timing: start 4β14d post-stroke depending on size/bleed risk.
- β€οΈ Underlying cardiac care: heart failure optimisation, valve surgery, tumour excision if relevant.
- π‘ Risk factor control: BP, DM, statins, smoking cessation.
- π€ Team approach: neuro + cardiology + stroke rehab.
π Prognosis
- β¬οΈ More severe strokes (large artery occlusion).
- β°οΈ Higher early mortality vs other stroke subtypes.
- π High recurrence risk if no anticoagulation.
- 𦽠Often require prolonged rehab; less likely to be fully independent.
π References
- Hart RG, Diener HC, Coutts SB. Embolic strokes of undetermined source. Lancet Neurol. 2014.
- Adams HP Jr et al. TOAST classification of stroke subtypes. Stroke. 1993.
- January CT et al. 2019 AHA/ACC/HRS AF management update. Circulation. 2019.
- AHA/ASA. Guidelines for early management of acute ischaemic stroke. Stroke. 2019.
- Arboix A, AliΓ³ J. Cardioembolic Stroke. Curr Cardiol Rev. 2010.